Copenhagen, Denmark

Sven Hastrup


Average Co-Inventor Count = 4.5

ph-index = 13

Forward Citations = 443(Granted Patents)


Location History:

  • K.o slashed.benhavn V., DK (1997)
  • K.o slashed.benhavn NV, DK (1998)
  • København, DK (2003)
  • Kobenhavn NV, DK (2004 - 2005)
  • Copenhagen, DK (1991 - 2007)
  • Koebenhavn, DK (2016 - 2018)

Company Filing History:


Years Active: 1991-2018

Loading Chart...
23 patents (USPTO):Explore Patents

Title: Sven Hastrup - Innovator in Fusion Proteins

Introduction

Sven Hastrup, based in Copenhagen, Denmark, is a prominent inventor with a remarkable portfolio of 23 patents. His innovative work primarily revolves around the field of biotechnology, particularly focusing on fusion proteins that hold significant potential for medical applications.

Latest Patents

Among his most notable inventions is the patent for "MIC-1 fusion proteins and uses thereof." This invention details compounds that include fusion proteins comprised of a MIC-1 protein or its analog at the C-terminus, paired with a functional variant of human serum albumin at the N-terminus. These components are connected through a peptide linker, resulting in compounds that exhibit MIC-1 activity. The patent also highlights pharmaceutical compositions that incorporate these compounds alongside pharmaceutically acceptable excipients, emphasizing their medical usage.

Career Highlights

Sven Hastrup has made significant contributions to the biotechnology sector during his career. He has worked with notable companies such as Novo Nordisk A/S and Novozymes A/S. His expertise in the field has enabled him to lead and collaborate on groundbreaking projects, contributing to advancements in therapeutic solutions.

Collaborations

Throughout his career, Sven has collaborated with esteemed colleagues like Sven Branner and Dorrit A Aaslyng. Their joint efforts have bolstered the innovation landscape in biotechnology, promoting the development of novel medical treatments and therapies.

Conclusion

Sven Hastrup's extensive patent portfolio and collaborative efforts highlight his commitment to advancing medical technology through innovative research and development. His work on MIC-1 fusion proteins exemplifies the impact that dedicated inventors can have in transforming the field of biotechnology and improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…